{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:17:42Z","timestamp":1793089062287,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010391","name":"Tokyo Women's Medical University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010391","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Prolactinomas are usually managed with cabergoline, and surgery is reserved for strictly selected cases. Based on our surgical experience, we observed no recurrence in women who conceived and delivered after surgical remission. We therefore evaluated surgical outcomes and indications in pregnancy-seeking women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively reviewed 57 women who underwent surgery in 1998\u20132008 (median age 28.0\u00a0years) and identified predictors of remission and recurrence. Refined criteria (desiring pregnancy, enclosed-type tumor, and Knosp grade\u2009\u2264\u20092 with anticipated complete resection) were then applied to 135 women treated in 2009\u20132022 (median age 35.0\u00a0years).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In 1998\u20132008, remission was achieved in 73.8% of enclosed-type microadenomas and improved to 95.2% in the later period. Postoperative prolactin\u2009&lt;\u20093\u00a0ng\/mL predicted lower recurrence than 3\u201315\u00a0ng\/mL (4.3% vs 50.0%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0098). In 2009\u20132022, 25\/135 (18.5%) underwent surgery. Of 32 women who met the refined criteria, 20 elected surgery, and all achieved remission without new deficits. Across both cohorts, 59 women of childbearing age achieved remission. Recurrence occurred in 6 of 30 women who did not conceive (20%) but in none of the 29 who conceived and delivered (0%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0237).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Pregnancy and delivery following surgical remission were associated with no recurrence, suggesting a potential cure in this subgroup. When performed by experienced pituitary surgeons, transsphenoidal surgery may offer a curative pathway for carefully selected women desiring pregnancy. These findings support further refinement of surgical candidacy in pregnancy-seeking women and warrant validation in larger cohorts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11102-026-01648-y","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T07:53:43Z","timestamp":1774425223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pregnancy and delivery after surgical remission in women with prolactinomas desiring pregnancy: Refining surgical indications"],"prefix":"10.1007","volume":"29","author":[{"given":"Kosaku","family":"Amano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihori","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhiro","family":"Ichihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takakazu","family":"Kawamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"issue":"2","key":"1648_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","volume":"65","author":"FF Casanueva","year":"2006","unstructured":"Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD et al (2006) Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) 65(2):265\u2013273. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02562.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"13","key":"1648_CR2","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1056\/NEJMcp0912025","volume":"362","author":"A Klibanski","year":"2010","unstructured":"Klibanski A (2010) Clinical practice. Prolactinomas. N Engl J Med 362(13):1219\u20131226. https:\/\/doi.org\/10.1056\/NEJMcp0912025","journal-title":"N Engl J Med"},{"issue":"12","key":"1648_CR3","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.1210\/jc.2007-2758","volume":"93","author":"M Ono","year":"2008","unstructured":"Ono M, Miki N, Kawamata T, Makino R, Amano K, Seki T et al (2008) Prospective study of high-dose cabergoline treatment of prolactinomas in 150 patients. J Clin Endocrinol Metab 93(12):4721\u20134727. https:\/\/doi.org\/10.1210\/jc.2007-2758","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1648_CR4","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1210\/jc.2009-2605","volume":"95","author":"M Ono","year":"2010","unstructured":"Ono M, Miki N, Amano K, Kawamata T, Seki T, Makino R et al (2010) Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas. J Clin Endocrinol Metab 95(6):2672\u20132679. https:\/\/doi.org\/10.1210\/jc.2009-2605","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1648_CR5","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jama.2016.19699","volume":"317","author":"ME Molitch","year":"2017","unstructured":"Molitch ME (2017) Diagnosis and treatment of pituitary adenomas: a review. JAMA 317(5):516\u2013524. https:\/\/doi.org\/10.1001\/jama.2016.19699","journal-title":"JAMA"},{"issue":"10","key":"1648_CR6","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1056\/NEJMra1810772","volume":"382","author":"S Melmed","year":"2020","unstructured":"Melmed S (2020) Pituitary-tumor endocrinopathies. N Engl J Med 382(10):937\u2013950. https:\/\/doi.org\/10.1056\/NEJMra1810772","journal-title":"N Engl J Med"},{"issue":"3","key":"1648_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-21-0977","volume":"186","author":"R Cozzi","year":"2022","unstructured":"Cozzi R, Ambrosio MR, Attanasio R, Battista C, Bozzao A, Caputo M et al (2022) Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors. Eur J Endocrinol 186(3):1\u201333. https:\/\/doi.org\/10.1530\/EJE-21-0977","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"1648_CR8","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","volume":"19","author":"S Petersenn","year":"2023","unstructured":"Petersenn S, Fleseriu M, Casanueva FF, Giustina A, Biermasz N, Biller BMK et al (2023) Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Rev Endocrinol 19(12):722\u2013740. https:\/\/doi.org\/10.1038\/s41574-023-00886-5","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"1648_CR9","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1210\/clinem\/dgad174","volume":"108","author":"RS Auriemma","year":"2023","unstructured":"Auriemma RS, Pirchio R, Pivonello C, Garifalos F, Colao A, Pivonello R (2023) Approach to the patient with prolactinoma. J Clin Endocrinol Metab 108(9):2400\u20132423. https:\/\/doi.org\/10.1210\/clinem\/dgad174","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1648_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2176\/jns-nmc.2023-0184","volume":"64","author":"K Amano","year":"2024","unstructured":"Amano K, Oda Y, Seki Y, Yamashita K, Bokuda K, Ichihara A et al (2024) Reconsideration of surgical indication for prolactin-producing pituitary tumor focusing on visual impairment. Neurol Med Chir (Tokyo) 64(4):160\u2013167. https:\/\/doi.org\/10.2176\/jns-nmc.2023-0184","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"1","key":"1648_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1530\/EJE-07-0248","volume":"158","author":"J Kreutzer","year":"2008","unstructured":"Kreutzer J, Buslei R, Wallaschofski H, Hofmann B, Nimsky C, Fahlbusch R et al (2008) Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients. Eur J Endocrinol 158(1):11\u201318. https:\/\/doi.org\/10.1530\/EJE-07-0248","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"1648_CR12","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.clineuro.2013.02.016","volume":"115","author":"H Ikeda","year":"2013","unstructured":"Ikeda H, Watanabe K, Tominaga T, Yoshimoto T (2013) Transsphenoidal microsurgical results of female patients with prolactinomas. Clin Neurol Neurosurg 115(9):1621\u20131625. https:\/\/doi.org\/10.1016\/j.clineuro.2013.02.016","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"1648_CR13","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s12020-014-0281-3","volume":"47","author":"R Salvatori","year":"2014","unstructured":"Salvatori R (2014) Surgical treatment of microprolactinomas: pros. Endocrine 47(3):725\u2013729. https:\/\/doi.org\/10.1007\/s12020-014-0281-3","journal-title":"Endocrine"},{"issue":"11","key":"1648_CR14","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.jocn.2015.06.001","volume":"22","author":"TR Smith","year":"2015","unstructured":"Smith TR, Hulou MM, Huang KT, Gokoglu A, Cote DJ, Woodmansee WW et al (2015) Current indications for the surgical treatment of prolactinomas. J Clin Neurosci 22(11):1785\u20131791. https:\/\/doi.org\/10.1016\/j.jocn.2015.06.001","journal-title":"J Clin Neurosci"},{"issue":"10","key":"1648_CR15","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.jocn.2015.03.059","volume":"22","author":"A Wong","year":"2015","unstructured":"Wong A, Eloy JA, Couldwell WT, Liu JK (2015) Update on prolactinomas. Part 2: treatment and management strategies. J Clin Neurosci 22(10):1568\u20131574. https:\/\/doi.org\/10.1016\/j.jocn.2015.03.059","journal-title":"J Clin Neurosci"},{"issue":"1","key":"1648_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000497331","volume":"109","author":"M Buchfelder","year":"2019","unstructured":"Buchfelder M, Zhao Y, Schlaffer S-M (2019) Surgery for prolactinomas to date. Neuroendocrinology 109(1):77\u201381. https:\/\/doi.org\/10.1159\/000497331","journal-title":"Neuroendocrinology"},{"issue":"6","key":"1648_CR17","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1530\/EJE-21-0293","volume":"185","author":"B Baussart","year":"2021","unstructured":"Baussart B, Villa C, Jouinot A, Raffin-Sanson M-L, Foubert L, Cazabat L, Bernier M, Bonnet F, Dohan A, Bertherat J, Assi\u00e9 G, Gaillard S (2021) Pituitary surgery as alternative to dopamine agonists treatment for microprolactinomas: a cohort study. Eur J Endocrinol 185(6):783\u2013791. https:\/\/doi.org\/10.1530\/EJE-21-0293","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1648_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-023-02199-7","volume":"46","author":"A Kalyvas","year":"2023","unstructured":"Kalyvas A, Almeida JP, Nassiri F, Lau R, O\u2019Halloran PJ, Mohan N et al (2023) Endoscopic endonasal surgery for prolactinomas: prognostic factors for disease control and management of persistent disease. Neurosurg Rev 46(1):295. https:\/\/doi.org\/10.1007\/s10143-023-02199-7","journal-title":"Neurosurg Rev"},{"issue":"10","key":"1648_CR19","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1210\/jc.2016-2008","volume":"101","author":"A Faje","year":"2016","unstructured":"Faje A, Chunharojrith P, Nency J, Biller BMK, Swearingen B, Klibanski A (2016) Dopamine agonists can reduce cystic prolactinomas. J Clin Endocrinol Metab 101(10):3709\u20133715. https:\/\/doi.org\/10.1210\/jc.2016-2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1648_CR20","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11102-016-0766-6","volume":"20","author":"T Ogiwara","year":"2017","unstructured":"Ogiwara T, Horiuchi T, Nagm A, Goto T, Hongo K (2017) Significance of surgical management for cystic prolactinoma. Pituitary 20(2):225\u2013230. https:\/\/doi.org\/10.1007\/s11102-016-0766-6","journal-title":"Pituitary"},{"issue":"4","key":"1648_CR21","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s11102-018-0888-0","volume":"21","author":"A Nakhleh","year":"2018","unstructured":"Nakhleh A, Shehadeh N, Hochberg I, Benbassat C, Olchovsky D, Tordjman K et al (2018) Management of cystic prolactinomas: a review. Pituitary 21(4):425\u2013430. https:\/\/doi.org\/10.1007\/s11102-018-0888-0","journal-title":"Pituitary"},{"key":"1648_CR22","doi-asserted-by":"publisher","first-page":"e832","DOI":"10.1016\/j.wneu.2023.04.031","volume":"175","author":"Y Oda","year":"2023","unstructured":"Oda Y, Amano K, Masui K, Kawamata T (2023) Clinical features of pituitary or parasellar tumor onset with cranial nerve palsy: surgical intervention considerations. World Neurosurg 175:e832\u2013e840. https:\/\/doi.org\/10.1016\/j.wneu.2023.04.031","journal-title":"World Neurosurg"},{"key":"1648_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.wneu.2015.10.090","volume":"87","author":"PR Jethwa","year":"2016","unstructured":"Jethwa PR, Patel TD, Hajart AF, Eloy JA, Couldwell WT, Liu JK (2016) Cost-effectiveness analysis of microscopic and endoscopic transsphenoidal surgery versus medical therapy in the management of microprolactinoma in the United States. World Neurosurg 87:65\u201376. https:\/\/doi.org\/10.1016\/j.wneu.2015.10.090","journal-title":"World Neurosurg"},{"issue":"2","key":"1648_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1055\/s-0036-1592193","volume":"78","author":"CC Zygourakis","year":"2017","unstructured":"Zygourakis CC, Imber BS, Chen R, Han SJ, Blevins L, Molinaro A et al (2017) Cost-effectiveness analysis of surgical versus medical treatment of prolactinomas. J Neurol Surg B Skull Base 78(2):125\u2013131. https:\/\/doi.org\/10.1055\/s-0036-1592193","journal-title":"J Neurol Surg B Skull Base"},{"key":"1648_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.clineuro.2018.11.024","volume":"176","author":"N Lamba","year":"2019","unstructured":"Lamba N, Noormohamed N, Simjian T, Alsheikh MY, Jamal A, Doucette J et al (2019) Fertility after transsphenoidal surgery in patients with prolactinomas: a meta-analysis. Clin Neurol Neurosurg 176:53\u201360. https:\/\/doi.org\/10.1016\/j.clineuro.2018.11.024","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"1648_CR26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1210\/jc.2012-3039","volume":"98","author":"RS Auriemma","year":"2013","unstructured":"Auriemma RS, Perone Y, Di Sarno A, Grasso LFS, Guerra E, Gasperi M et al (2013) Results of a single-center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation. J Clin Endocrinol Metab 98(1):372\u2013379. https:\/\/doi.org\/10.1210\/jc.2012-3039","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1648_CR27","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1080\/09513590.2016.1254177","volume":"33","author":"A Rastogi","year":"2017","unstructured":"Rastogi A, Bhadada SK, Bhansali A (2017) Pregnancy and tumor outcomes in infertile women with macroprolactinoma on cabergoline therapy. Gynecol Endocrinol 33(4):270\u2013273. https:\/\/doi.org\/10.1080\/09513590.2016.1254177","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"1648_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1210\/jc.2009-1238","volume":"95","author":"OM Dekkers","year":"2010","unstructured":"Dekkers OM, Lagro J, Burman P, J\u00f8rgensen JO, Romijn JA, Pereira AM (2010) Recurrence of hyperprolactinemia after withdrawal of dopamine agonists: systematic review and meta-analysis. J Clin Endocrinol Metab 95(1):43\u201351. https:\/\/doi.org\/10.1210\/jc.2009-1238","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1648_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10143-015-0667-6","volume":"39","author":"K Amano","year":"2016","unstructured":"Amano K, Hori T, Kawamata T, Okada Y (2016) Repair and prevention of cerebrospinal fluid leakage in transsphenoidal surgery: a sphenoid sinus mucosa technique. Neurosurg Rev 39(1):123\u2013131. https:\/\/doi.org\/10.1007\/s10143-015-0667-6","journal-title":"Neurosurg Rev"},{"issue":"1","key":"1648_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-025-03767-9","volume":"48","author":"K Amano","year":"2025","unstructured":"Amano K, Oda Y, Kawamata T (2025) Optimizing dural opening and closure in endonasal transsphenoidal surgery: technical considerations for incision design and clinical utility. Neurosurg Rev 48(1):616. https:\/\/doi.org\/10.1007\/s10143-025-03767-9","journal-title":"Neurosurg Rev"},{"issue":"1","key":"1648_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10143-007-0108-2","volume":"31","author":"T Kawamata","year":"2008","unstructured":"Kawamata T, Amano K, Hori T (2008) Novel flexible forceps for endoscopic transsphenoidal resection of pituitary tumors: technical report. Neurosurg Rev 31(1):65\u201368. https:\/\/doi.org\/10.1007\/s10143-007-0108-2","journal-title":"Neurosurg Rev"},{"issue":"2","key":"1648_CR32","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s10143-019-01090-8","volume":"42","author":"K Amano","year":"2019","unstructured":"Amano K, Okada Y, Kawamata T (2019) Usefulness of the knot-tightener device following dural suturing in endonasal transsphenoidal surgery: technical report. Neurosurg Rev 42(2):593\u2013598. https:\/\/doi.org\/10.1007\/s10143-019-01090-8","journal-title":"Neurosurg Rev"},{"issue":"3","key":"1648_CR33","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/1553350620969000","volume":"28","author":"S Suzuki","year":"2021","unstructured":"Suzuki S, Kobayashi E, Hododuka K, Amano K, Masamune K, Muragaki Y (2021) Development of a semiautomatic dura mater suturing device for preventing cerebrospinal fluid leakage in transsphenoidal surgery. Surg Innov 28(3):374\u2013377. https:\/\/doi.org\/10.1177\/1553350620969000","journal-title":"Surg Innov"},{"key":"1648_CR34","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.wneu.2021.04.027","volume":"151","author":"T Kawamata","year":"2021","unstructured":"Kawamata T, Amano K (2021) Novel bendable ring curette for endoscopic transsphenoidal surgery for pituitary tumors. World Neurosurg 151:284\u2013289. https:\/\/doi.org\/10.1016\/j.wneu.2021.04.027","journal-title":"World Neurosurg"},{"issue":"4","key":"1648_CR35","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00701-018-03778-0","volume":"161","author":"K Amano","year":"2019","unstructured":"Amano K, Aihara Y, Tsuzuki S, Okada Y, Kawamata T (2019) Application of indocyanine green fluorescence endoscopic system in transsphenoidal surgery for pituitary tumors. Acta Neurochir (Wien) 161(4):695\u2013706. https:\/\/doi.org\/10.1007\/s00701-018-03778-0","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"1648_CR36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10143-005-0384-7","volume":"28","author":"T Kawamata","year":"2005","unstructured":"Kawamata T, Kubo O, Hori T (2005) Surgical removal of growth hormone-secreting pituitary adenomas with intensive microsurgical pseudocapsule resection results in complete remission of acromegaly. Neurosurg Rev 28(3):201\u2013208. https:\/\/doi.org\/10.1007\/s10143-005-0384-7","journal-title":"Neurosurg Rev"},{"issue":"3","key":"1648_CR37","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3171\/2014.3.JNS132214","volume":"121","author":"H Nishioka","year":"2014","unstructured":"Nishioka H, Fukuhara N, Horiguchi K, Yamada S (2014) Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcome. J Neurosurg 121(3):505\u2013510. https:\/\/doi.org\/10.3171\/2014.3.JNS132214","journal-title":"J Neurosurg"},{"issue":"5","key":"1648_CR38","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/cen.12370","volume":"80","author":"M-E Domingue","year":"2014","unstructured":"Domingue M-E, Devuyst F, Alexopoulou O, Corvilain B, Maiter D (2014) Outcome of prolactinoma after pregnancy and lactation: a study on 73 patients. Clin Endocrinol (Oxf) 80(5):642\u2013648. https:\/\/doi.org\/10.1111\/cen.12370","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1648_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2015.00085","volume":"6","author":"MH Almalki","year":"2015","unstructured":"Almalki MH, Alzahrani S, Alshahrani F, Alsherbeni S, Almoharib O, Aljohani N et al (2015) Managing prolactinomas during pregnancy. Front Endocrinol (Lausanne) 6:85. https:\/\/doi.org\/10.3389\/fendo.2015.00085","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"1648_CR40","doi-asserted-by":"publisher","first-page":"559","DOI":"10.4103\/ijem.ijem_372_21","volume":"25","author":"BA Laway","year":"2021","unstructured":"Laway BA, Baba MS, Bansiwal SK, Choh NA (2021) Prolactinoma outcome after pregnancy and lactation: a cohort study. Indian J Endocrinol Metab 25(6):559\u2013562. https:\/\/doi.org\/10.4103\/ijem.ijem_372_21","journal-title":"Indian J Endocrinol Metab"},{"issue":"6","key":"1648_CR41","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1210\/edrv.22.6.0451","volume":"22","author":"N Ben-Jonathan","year":"2001","unstructured":"Ben-Jonathan N, Hnasko R (2001) Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 22(6):724\u2013763. https:\/\/doi.org\/10.1210\/edrv.22.6.0451","journal-title":"Endocr Rev"},{"issue":"5","key":"1648_CR42","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrendo.2015.36","volume":"11","author":"V Bernard","year":"2015","unstructured":"Bernard V, Young J, Chanson P, Binart N (2015) New insights in prolactin: pathological implications. Nat Rev Endocrinol 11(5):265\u2013275. https:\/\/doi.org\/10.1038\/nrendo.2015.36","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"1648_CR43","doi-asserted-by":"publisher","first-page":"T101","DOI":"10.1530\/JOE-15-0213","volume":"226","author":"DR Grattan","year":"2015","unstructured":"Grattan DR (2015) 60 years of neuroendocrinology: the hypothalamo\u2013prolactin axis. J Endocrinol 226(2):T101-122. https:\/\/doi.org\/10.1530\/JOE-15-0213","journal-title":"J Endocrinol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01648-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01648-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01648-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:49:52Z","timestamp":1781642992000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-026-01648-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1648"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01648-y","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"The authors have nothing to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}],"article-number":"58"}}